A Slc38a8 Mouse Model of FHONDA Syndrome Faithfully Recapitulates the Visual Deficits of Albinism Without Pigmentation Defects.


Journal

Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701

Informations de publication

Date de publication:
03 10 2023
Historique:
medline: 27 10 2023
pubmed: 20 10 2023
entrez: 20 10 2023
Statut: ppublish

Résumé

We aimed to generate and phenotype a mouse model of foveal hypoplasia, optic nerve decussation defects, and anterior segment dysgenesis (FHONDA), a rare disease associated with mutations in Slc38a8 that causes severe visual alterations similar to albinism without affecting pigmentation. The FHONDA mouse model was generated with clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 technology using an RNA guide targeting the Scl38a8 murine locus. The resulting mice were backcrossed to C57BL/6J. Melanin content was measured using spectrophotometry. Retinal cell architecture was analyzed through light and electron microscopy. Retinal projections to the brain were evaluated with anterograde labelling in embryos and adults. Visual function was assessed by electroretinography (ERG) and the optomotor test (OT). From numerous Slc38a8 mouse mutant alleles generated, we selected one that encodes a truncated protein (p.196Pro*, equivalent to p.199Pro* in the human protein) closely resembling a mutant allele described in patients (p.200Gln*). Slc38a8 mutant mice exhibit wild-type eye and coat pigmentation with comparable melanin content. Subcellular abnormalities were observed in retinal pigment epithelium cells of Slc38a8 mutant mice. Anterograde labeling experiments of retinal projections in embryos and adults showed a reduction of ipsilateral fibers. Functional visual analyses revealed a decreased ERG response in scotopic conditions and a reduction of visual acuity in mutant mice measured by OT. Slc38a8 mutant mice recapitulate the phenotype of patients with FHONDA concerning their normal pigmentation and their abnormal visual system, in the latter being a hallmark of all types of albinism. These mice will be helpful in better understanding the pathophysiology of this genetic condition.

Identifiants

pubmed: 37862028
pii: 2792946
doi: 10.1167/iovs.64.13.32
pmc: PMC10599165
doi:

Substances chimiques

Melanins 0
Slc38a8 protein, human 0
Amino Acid Transport Systems, Neutral 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

32

Références

J Neurosci. 2012 Apr 4;32(14):4821-6
pubmed: 22492037
Sci Rep. 2019 Nov 12;9(1):16576
pubmed: 31719542
Hum Mol Genet. 2020 Nov 4;29(18):2989-3002
pubmed: 32744312
Invest Ophthalmol Vis Sci. 2022 Jan 3;63(1):19
pubmed: 35029636
Int J Mol Sci. 2021 Jan 24;22(3):
pubmed: 33498813
Invest Ophthalmol Vis Sci. 2020 Aug 3;61(10):1
pubmed: 32744596
Doc Ophthalmol. 2021 Dec;143(3):323-330
pubmed: 34037952
Neuroimage. 2019 Apr 15;190:224-231
pubmed: 29524626
Nucleic Acids Res. 2015 May 26;43(10):4855-67
pubmed: 25897126
Genes (Basel). 2022 Jun 27;13(7):
pubmed: 35885947
Curr Protoc Hum Genet. 2014 Oct 01;83:15.7.1-27
pubmed: 25271839
Dev Biol. 1994 Dec;166(2):460-4
pubmed: 7813769
Am J Hum Genet. 2013 Dec 5;93(6):1143-50
pubmed: 24290379
Elife. 2020 Feb 25;9:
pubmed: 32096760
Jpn J Ophthalmol. 2018 Jul;62(4):481-490
pubmed: 29691783
Mol Vis. 2013 Nov 01;19:2165-72
pubmed: 24194637
Exp Eye Res. 2020 Apr;193:107958
pubmed: 32032626
Hum Genet. 2023 Aug;142(8):1077-1089
pubmed: 36445457
Pigment Cell Melanoma Res. 2021 Jul;34(4):786-799
pubmed: 33960688
J Neurosci. 2009 Nov 25;29(47):14855-63
pubmed: 19940181
Curr Protoc Mouse Biol. 2020 Mar;10(1):e69
pubmed: 32159922
Genesis. 2001 May;30(1):21-5
pubmed: 11353514
J Neurochem. 2006 Feb;96(4):1201-11
pubmed: 16445854
Transgenic Res. 2011 Apr;20(2):435-40
pubmed: 20632206
Pigment Cell Melanoma Res. 2014 May;27(3):325-6
pubmed: 24517096
Pigment Cell Melanoma Res. 2014 Jan;27(1):11-8
pubmed: 24066960
Genet Med. 2021 Mar;23(3):479-487
pubmed: 33100333
Front Biosci. 2006 Jan 01;11:743-52
pubmed: 16146766
Cells. 2021 Nov 15;10(11):
pubmed: 34831401
Brain Res Dev Brain Res. 1997 Mar 17;99(1):95-102
pubmed: 9088570
Pigment Cell Res. 2004 Aug;17(4):363-70
pubmed: 15250938
Int J Mol Sci. 2021 May 20;22(10):
pubmed: 34065385
Mol Genet Genomic Med. 2017 Feb 26;5(3):202-209
pubmed: 28546991
Ophthalmic Genet. 2023 Feb 7;:1-4
pubmed: 36748941
Eur J Hum Genet. 2014 May;22(5):703-6
pubmed: 24045842
Pigment Cell Melanoma Res. 2021 Mar;34(2):212-221
pubmed: 33098271
J Mol Biol. 2015 Mar 27;427(6 Pt B):1495-1512
pubmed: 25451601
Br J Ophthalmol. 2006 Sep;90(9):1098-102
pubmed: 16707527
J Dermatol. 2013 May;40(5):319-24
pubmed: 23668539
Prog Retin Eye Res. 2022 Nov;91:101091
pubmed: 35729001
Ophthalmology. 2022 Jun;129(6):708-718
pubmed: 35157951
Brain. 2019 Jan 1;143(1):303-319
pubmed: 31855245
Stem Cell Reports. 2022 Jan 11;17(1):173-186
pubmed: 35021041

Auteurs

Ana Guardia (A)

Department of Molecular and Cellular Biology, National Centre for Biotechnology (CNB-CSIC), Madrid, Spain.
Centre for Biomedical Network Research on Rare Diseases (CIBERER-ISCIII), Madrid, Spain.

Almudena Fernández (A)

Department of Molecular and Cellular Biology, National Centre for Biotechnology (CNB-CSIC), Madrid, Spain.
Centre for Biomedical Network Research on Rare Diseases (CIBERER-ISCIII), Madrid, Spain.

Davide Seruggia (D)

Department of Molecular and Cellular Biology, National Centre for Biotechnology (CNB-CSIC), Madrid, Spain.
Centre for Biomedical Network Research on Rare Diseases (CIBERER-ISCIII), Madrid, Spain.

Virginie Chotard (V)

Sorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France.

Carla Sánchez-Castillo (C)

Department of Physiology, Genetics and Microbiology, University of Alicante, Alicante, Spain.

Oksana Kutsyr (O)

Department of Optics, Pharmacology and Anatomy, University of Alicante, Alicante, Spain.

Xavier Sánchez-Sáez (X)

Department of Physiology, Genetics and Microbiology, University of Alicante, Alicante, Spain.

Esther Zurita (E)

Department of Molecular and Cellular Biology, National Centre for Biotechnology (CNB-CSIC), Madrid, Spain.
Centre for Biomedical Network Research on Rare Diseases (CIBERER-ISCIII), Madrid, Spain.

Marta Cantero (M)

Department of Molecular and Cellular Biology, National Centre for Biotechnology (CNB-CSIC), Madrid, Spain.
Centre for Biomedical Network Research on Rare Diseases (CIBERER-ISCIII), Madrid, Spain.

Alexandra Rebsam (A)

Sorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France.

Nicolás Cuenca (N)

Department of Physiology, Genetics and Microbiology, University of Alicante, Alicante, Spain.

Lluís Montoliu (L)

Department of Molecular and Cellular Biology, National Centre for Biotechnology (CNB-CSIC), Madrid, Spain.
Centre for Biomedical Network Research on Rare Diseases (CIBERER-ISCIII), Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH